SLC3A2 and hepatocellular carcinoma: As shown in Figure 5C, the expression levels of CD98, β1-integrin-A and Ki-67 were significantly increased in HCC samples from stage T3–4 patients, compared to the levels in HCC samples from stage T1–2 patients.